| References |
| 1 |
Metabolites of naloxone in human urine
|
| 2 |
Effect of naloxone-3-glucuronide and N-methylnaloxone on the motility of the isolated rat colon after morphine
|
| 3 |
Optimization of Mass Spectrometry Imaging for Drug Metabolism and Distribution Studies in the Zebrafish Larvae Model: A Case Study with the Opioid Antagonist Naloxone
|
| 4 |
PBPK Modeling as a Tool for Predicting and Understanding Intestinal Metabolism of Uridine 5'-Diphospho-glucuronosyltransferase Substrates
|
| 5 |
Exposure to oral oxycodone is increased by concomitant inhibition of CYP2D6 and 3A4 pathways, but not by inhibition of CYP2D6 alone. Br J Clin Pharmacol. 2010 Jul;70(1):78-87.
|
| 6 |
Quantitative contribution of CYP2D6 and CYP3A to oxycodone metabolism in human liver and intestinal microsomes. Drug Metab Dispos. 2004 Apr;32(4):447-54.
|
| 7 |
Enzalutamide Reduces Oxycodone Exposure in Men with Prostate Cancer. Clin Pharmacokinet. 2023 May 10. doi: 10.1007/s40262-023-01255-1.
|
| 8 |
Metabolism and Disposition of Prescription Opioids: A Review
|
| 9 |
DrugBank(Pharmacology-Metabolism)Oxycodone hydrochloride
|
| 10 |
In vitro investigations into the roles of CYP450 enzymes and drug transporters in the drug interactions of zanubrutinib, a covalent Bruton's tyrosine kinase inhibitor
|
